ARCHIVES

On “Day One Of Post-Genome World,” Eric Lander Recounts 15-Year Journey.

This article is from The Cancer Letter archive.

Vol. 27 No. 07 | February 16, 2001

Download PDF Visit The Full Archive

Related Articles

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

March 23, 1994

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

April 4, 1975

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012

NCAB Subcommittee Works On Drafting Quantitative Risk Assessment Policy

October 1, 1982

In Brief: King ACCC President, Fleming President Elect; Wyngaarden Says He Doesn’t Oppose Panel

March 25, 1988